Medication Prescription filling Services for ODOC

The Oklahoma Department of Corrections (ODOC) has issued Solicitation Number EV00000600 for comprehensive medication prescription filling services across 23 ODOC facilities, seeking a vendor to provide daily multi-dose automated tablet packaging systems for approximately 19,000 inmates. The solicitation requires suppliers to deliver medications daily or up to 3 days in advance for holidays/weekends, with an estimated 500,000 prescription fills annually and an average monthly pharmacy expenditure of $1,921,736.62. Bidders must demonstrate a minimum of 10 years documented experience serving private, federal, state, and/or local jail systems of similar size, and must maintain HIPAA compliance while interfacing with ODOC's Electronic Health Record system. The contract will be awarded on a best value basis, with ability to meet specifications evaluated as pass/fail and lowest price among qualified bidders being scored. Key submission deadlines include February 4, 2025 at 1:00 PM CST for proposal submission, with administrative review requests due by December 6, 2024, and questions due by December 17, 2024.

The procurement allows for potential statewide contract implementation with an initial one-year term and four optional one-year renewals. Bidders must complete several mandatory forms including a Non-Collusion Certification (Form CP004), Responding Bidder Information form (OMES Form CP076), and execute various attachments covering security requirements, PREA compliance, and IT terms. While no specific set-aside designations are explicitly noted, the state encourages participation from service-disabled veteran businesses. The incumbent provider is identified as Pharmacorr, and the contract excludes 340B program medications, which are handled separately through Lindsay Municipal Hospital. Vendors must provide comprehensive monthly reporting capabilities, including usage patterns, cost analyses, medication errors, and quality assurance reviews. Pricing should be based on actual medication acquisition cost plus a dispensing fee, with the current fill fee at $1.85 and estimated annual rebates of $1.7 million. Financial viability will be determined by the evaluation team, with suppliers required to submit three business references and up to three years of financial statements and tax returns.